GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cynata Therapeutics Ltd (ASX:CYP) » Definitions » Price-to-Tangible-Book

Cynata Therapeutics (ASX:CYP) Price-to-Tangible-Book : 5.09 (As of May. 28, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Cynata Therapeutics Price-to-Tangible-Book?

As of today (2024-05-28), Cynata Therapeutics's share price is A$0.29. Cynata Therapeutics's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$0.06. Hence, Cynata Therapeutics's Price to Tangible Book Ratio of today is 5.09.

The historical rank and industry rank for Cynata Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

ASX:CYP' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.54   Med: 4.69   Max: 16.33
Current: 4.83

During the past 13 years, Cynata Therapeutics's highest Price to Tangible Book Ratio was 16.33. The lowest was 1.54. And the median was 4.69.

ASX:CYP's Price-to-Tangible-Book is ranked worse than
70.93% of 1221 companies
in the Biotechnology industry
Industry Median: 2.79 vs ASX:CYP: 4.83

A closely related ratio is called PB Ratio. As of today, Cynata Therapeutics's share price is A$0.29. Cynata Therapeutics's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.07. Hence, Cynata Therapeutics's P/B Ratio of today is 4.26.


Cynata Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Cynata Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cynata Therapeutics Price-to-Tangible-Book Chart

Cynata Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.33 5.15 2.82 2.40 1.54

Cynata Therapeutics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.08 2.40 2.56 1.54 2.19

Competitive Comparison of Cynata Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Cynata Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cynata Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cynata Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Cynata Therapeutics's Price-to-Tangible-Book falls into.



Cynata Therapeutics Price-to-Tangible-Book Calculation

Cynata Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=0.29/0.057
=5.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Cynata Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Cynata Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Cynata Therapeutics (ASX:CYP) Business Description

Traded in Other Exchanges
Address
100 Cubitt Street, Level 3, Cremorne, VIC, AUS, 3121
Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus. There are currently three active clinical trials taking place using Cymerus technology which are attempting to treat osteoarthritis, respiratory distress, and diabetic foot ulcers.

Cynata Therapeutics (ASX:CYP) Headlines

No Headlines